A comprehensive view of Bayer AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
Bayer AG Champions Cellular and Gene Therapy Innovation, Advocates for Sustainable Agriculture, and Explores AI in Stroke Diagnosis
Published:
May 11, 2024
by Industry Intelligence Inc.
|
Roche's Vabysmo sales reach US$927.0M in Q1 2024; Vabysmo poses challenge to Regeneron and Bayer's Eylea HD in the treatment spaces of wet age-related macular degeneration, diabetic macular edema, and macular edema: GlobalData.
Published:
May 10, 2024
by ForeignAffairs.co.nz
|
Bayer AG Tops Employer Rankings in Spain and Launches Digital Agriculture Initiative in India, Empowering Over 500,000 Farmers
Published:
May 10, 2024
by Industry Intelligence Inc.
|
Bayer AG Champions Precision Agriculture for Climate Action and Mental Health in Farming, Invests in Rare Disease Support and Allergy Relief Initiatives
Published:
May 08, 2024
by Industry Intelligence Inc.
|
Bayer AG Leverages Digital Health Tools and Advocates for Sustainable Agriculture and Women's Health
Published:
May 07, 2024
by Industry Intelligence Inc.
|
Ask us about our Transformation & Innovation market view